Our Focus

Crystal structure of uPAR (PDB ID: 1YWH). Reproduced from Llinas, P. et al., Crystal structure of the human urokinase
plasminogen activator receptor bound to an antagonist peptide. EMBO J. 2005, 24, 1655-1663.

IRIDEA is devoted to the development of small-molecule biomimetic compounds, acting as highly effective antiangiogenic and antinflammatory agents. Our proprietary molecules are selected on the basis of a rational design process and synthesized by standard organic chemistry methodologies. Compared to the existing candidates for the same end, our compounds are conceived as inexpensive drug substances for oral administration, enabling friendly home treatment, reducing hospital admissions and caring. Our motto is: “Safety First”.

%d blogger hanno fatto clic su Mi Piace per questo: